BioVie Inc.
BIVI
$1.03
-$0.06-5.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -19.67% | 12.29% | 6.78% | 2.26% | -21.66% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -61.35% | -16.95% | -62.10% | -56.36% | -43.87% |
| Operating Income | 61.35% | 16.95% | 62.10% | 56.36% | 43.87% |
| Income Before Tax | 65.44% | 15.34% | 61.23% | 45.78% | 46.36% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 65.44% | 15.34% | 61.23% | 45.78% | 46.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 65.44% | 15.34% | 61.23% | 45.78% | 46.36% |
| EBIT | 61.35% | 16.95% | 62.10% | 56.36% | 43.87% |
| EBITDA | 61.81% | 17.06% | 62.43% | 56.66% | 44.05% |
| EPS Basic | 92.46% | 79.31% | 76.01% | 67.82% | 53.06% |
| Normalized Basic EPS | 91.63% | 79.44% | 77.75% | 67.82% | 57.71% |
| EPS Diluted | 92.47% | 79.10% | 76.03% | 66.93% | 53.49% |
| Normalized Diluted EPS | 91.63% | 79.44% | 77.75% | 67.82% | 57.71% |
| Average Basic Shares Outstanding | 313.10% | 311.76% | 74.22% | 68.49% | 26.82% |
| Average Diluted Shares Outstanding | 313.10% | 311.76% | 74.22% | 68.49% | 26.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |